Remove technology-innovation-research
article thumbnail

STAT+: Jay Bradner, former Novartis research leader, to head up Amgen’s scientific efforts

STAT

Jay Bradner, a former top research leader at Novartis, is joining Amgen as its new chief scientific officer, the California company announced Thursday.   Reese is becoming the company’s chief technology officer.   Bradner is taking over for Amgen veteran David Reese in the role.

300
300
article thumbnail

Listen: AI in medicine, detangling hype, and Icelandic DNA

STAT

First, STAT’s Casey Ross joins us to explain his reporting on how researchers and pharmaceutical firms are using the technology to find new drug targets, design therapies, and improve clinical trials.

271
271
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

AlphaFold developers and eye scan inventors among Lasker Award winners for 2023

STAT

The prestigious Lasker Awards for biomedical research are sometimes referred to as “America’s Nobel,” and with good reason — about a fourth of Lasker laureates have gone on to receive the Swedish award, too. Read the rest…

266
266
article thumbnail

Opinion: Michael J. Fox: As a Parkinson’s patient, I felt a little left behind by biology’s century — until now

STAT

Last fall in STAT, Matt Herper questioned whether the biomedical research enterprise is really laying the necessary groundwork to gain the full benefit of innovation in “biology’s century.” Fox Foundation has been working to address just the biomedical research challenges Matt wrote about.

265
265
article thumbnail

Bayer extends Partnership with Peking University to foster Pharmaceutical Innovation in China

LifeProNow

July 10, 2023 : “Bayer and Peking University (PKU) will collaborate to foster the translation of basic pharmaceutical research into drug discovery and development, while accelerating scientific research on cutting-edge technologies across the pharmaceutical value chain.

130
130
article thumbnail

Takeda signs MoU with BIRAC to support healthcare start-ups

Express Pharma

Takeda announced the signing of a three-year MoU with the Biotechnology Industry Research Assistance Council (BIRAC), a public sector enterprise set up by the Department of Biotechnology, Government of India. The country’s healthcare segment offers an incredible opportunity both for innovation and growth.

108
108
article thumbnail

Case Study: MGI and Alacris Theranostics

pharmaphorum

This case study explores the collaborative efforts of MGI and Alacris Theranostics in utilising molecular tumour profiling technology for advanced research. Discover the impact of this innovative approach on personalised medicine and treatment strategies.

113
113